Is antenatal steroid treatment effective in preterm IUGR fetuses?

References

• Cunningham FG, MacDonald PC, Leveno KJ, Gant NF, Gilstrap LC. Williams obstetrics. Prentice-Hall, London 1993
   Google Scholar
• Economides DL, Nicolaides KH, Linton EA, Perry LA, Chard T. Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses. Fetal Ther. 1988; 3: 158–64
   PubMedGoogle Scholar
• McTernan CL, Draper N, Nicholson H, Chalder SM, Driver P, Hewison M, et al. Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J Clin Endocrinol Metab. 2001; 86: 4979–83
   PubMed Web of Science ®Google Scholar
• Piazze JJ, Maranghi L, Nigro G, Rizzo G, Cosmi EV, Anceschi MM. The effect of glucocorticoid therapy on fetal lung maturity indices in hypertensive pregnancies. Obstet Gynecol. 1998; 92: 220–5
   PubMed Web of Science ®Google Scholar
• Soregaroli M, Bonera R, Danti L, Dinolfo D, Taddei F, Valcamonico A, et al. Prognostic role of umbilical artery Doppler velocimetry in growth-restricted fetuses. J Matern Fetal Neonatal Med. 2002; 11: 199–203
   PubMedGoogle Scholar
• Sterne G, Shields LE, Dubinsky TJ. Abnormal fetal cerebral and umbilical Doppler measurements in fetuses with intrauterine growth restriction predicts the severity of perinatal morbidity. J Clin Ultrasound. 2001; 29: 146–51
   PubMed Web of Science ®Google Scholar
• Torrance HL, Mulder EJ, Brouwers HA, van Bel F, Visser GH. Respiratory outcome in preterm small for gestational age fetuses with or without abnormal umbilical artery Doppler and/or maternal hypertension. J Matern Fetal Neonatal Med. 2007; 20: 613–21
   PubMed Web of Science ®Google Scholar
• Torrance HL, Voorbij HA, Wijnberger LD, van Bel F, Visser GH. Lung maturation in small for gestational age fetuses from pregnancies complicated by placental insufficiency or maternal hypertension. Early Hum Dev. 2008; 84: 465–9
   PubMed Web of Science ®Google Scholar
• Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet. 2005; 365: 1856–62
   PubMed Web of Science ®Google Scholar
• Dalziel SR, Lim VK, Lambert A, McCarthy D, Parag V, Rodgers A, et al. Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ. 2005; 331: 665–671
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA. 1995;273:413–8.
   PubMed Web of Science ®Google Scholar
• Crowley, P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev. 2000;2:CD000065.
   Google Scholar
• Roberts, D, Dalziel, S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;3: CD004454.
   Web of Science ®Google Scholar
• Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972; 50: 515–25
   PubMed Web of Science ®Google Scholar
• Huang WL, Beazley LD, Quinlivan JA, Evans SF, Newnham JP, Dunlop SA. Effect of corticosteroids on brain growth in fetal sheep. Obstet Gynecol. 1999; 94: 213–8
   PubMed Web of Science ®Google Scholar
• Jobe AH, Wada N, Berry LM, Ikegami M, Ervin MG. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol. 1998; 178: 880–5
   PubMed Web of Science ®Google Scholar
• Miller SL, Chai M, Loose J, Castillo-Melendez M, Walker DW, Jenkin G, et al. The effects of maternal betamethasone administration on the intrauterine growth-restricted fetus. Endocrinology. 2007; 148: 1288–95
   PubMed Web of Science ®Google Scholar
• Barker DJ. In utero programming of chronic disease. Clin Sci (Lond) 1998; 95: 115–28
   PubMed Web of Science ®Google Scholar
• Wijnberger LD, Bilardo CM, Hecher K, Stigter RH, Visser GH. Effect of antenatal glucocorticoid therapy on arterial and venous blood flow velocity waveforms in severely growth-restricted fetuses. Ultrasound Obstet Gynecol. 2004; 23: 584–9
   PubMed Web of Science ®Google Scholar
• Simchen MJ, Alkazaleh F, Adamson SL, Windrim R, Telford J, Beyene J, et al. The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction. Am J Obstet Gynecol. 2004; 190: 296–304
   PubMed Web of Science ®Google Scholar
• Wallace EM, Baker LS. Effect of antenatal betamethasone administration on placental vascular resistance. Lancet. 1999; 353: 1404–7
   PubMed Web of Science ®Google Scholar
• Baud O, Foix-L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med. 1999; 341: 1190–6
   PubMed Web of Science ®Google Scholar
• Soothill PW, Bobrow CS, Holmes R. Small for gestational age is not a diagnosis. Ultrasound Obstet Gynecol. 1999; 13: 225–8
   PubMed Web of Science ®Google Scholar
• Burke G, Stuart B, Crowley P, Scanaill SN, Drumm J. Is intrauterine growth retardation with normal umbilical artery blood flow a benign condition?. BMJ. 1990; 300: 1044–5
   PubMed Web of Science ®Google Scholar
• Schaap AH, Wolf H, Bruinse HW, Smolders-De Haas H, Van EI, Treffers PE. Effects of antenatal corticosteroid administration on mortality and long-term morbidity in early preterm, growth-restricted infants. Obstet Gynecol. 2001; 97: 954–60
   PubMed Web of Science ®Google Scholar
• van Stralen, G, van der Bos, J, Lopriore, E, te Pas, AB, Bloemenkamp, KW, Walther, FJ, , et al. No short-term benefits of antenatal corticosteroid treatment in severely preterm growth restricted fetuses: a case-control study. Early Hum Dev. Apr, 2009;85(4)253–7. Epub 2008 Nov 22.
   PubMed Web of Science ®Google Scholar
• Spinillo A, Capuzzo E, Ometto A, Stronati M, Baltaro F, Iasci A. Value of antenatal corticosteroid therapy in preterm birth. Early Hum Dev. 1995; 42: 37–47
   PubMed Web of Science ®Google Scholar
• Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol. 2000; 182: 198–206
   PubMed Web of Science ®Google Scholar
• Elimian A, Verma U, Canterino J, Shah J, Visintainer P, Tejani N. Effectiveness of antenatal steroids in obstetric subgroups. Obstet Gynecol. 1999; 93: 174–9
   PubMed Web of Science ®Google Scholar
• Ley D, Wide-Swensson D, Lindroth M, Svenningsen N, Marsal K. Respiratory distress syndrome in infants with impaired intrauterine growth. Acta Paediatr. 1997; 86: 1090–6
   PubMed Web of Science ®Google Scholar
• Spinillo A, Viazzo F, Colleoni R, Chiara A, Maria CR, Fazzi E. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Am J Obstet Gynecol. 2004; 191: 217–24
   PubMed Web of Science ®Google Scholar
• Wapner RJ, Sorokin Y, Mele L, Johnson F, Dudley DJ, Spong CY, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med. 2007; 357: 1190–8
   PubMed Web of Science ®Google Scholar
• Gould JB, Gluck L, Kulovich MV. The relationship between accelerated pulmonary maturity and accelerated neurological maturity in certain chronically stressed pregnancies. Am J Obstet Gynecol. 1977; 127: 181–6
   PubMed Web of Science ®Google Scholar
• Torrance HL, Krediet TG, Vreman HJ, Visser GH, van Bel F. Oxidative stress and proinflammatory cytokine levels are increased in premature neonates of preeclamptic mothers with HELLP syndrome. Neonatology. 2008; 94: 138–42
   PubMed Web of Science ®Google Scholar
• Amorim MM, Santos LC, Faundes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol. 1999; 180: 1283–8
   PubMed Web of Science ®Google Scholar
• Schutte, MF. De waarde van corticosteroiden en thyroxinestimulatie bij groeivertraging [The value of corticosteroids and thyroxin stimulation in growth restriction]. In: Foetale aspecten van groeivertraging [Fetal aspects of growth restriction], (in Dutch). Amsterdam, Noord-Hollandthe Netherlands: Amsterdam University Press, 1992. pp. 92–8.
   Google Scholar